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The invertebrate blood-brain barrier (BBB) field is growing at a rapid pace and, in recent
years, studies have shown a physiologic and molecular complexity that has begun to
rival its vertebrate counterpart. Novel mechanisms of paracellular barrier maintenance
through G-protein coupled receptor signaling were the first demonstrations of the complex
adaptive mechanisms of barrier physiology. Building upon this work, the integrity of
the invertebrate BBB has recently been shown to require coordinated function of all
layers of the compound barrier structure, analogous to signaling between the layers of
the vertebrate neurovascular unit. These findings strengthen the notion that many BBB
mechanisms are conserved between vertebrates and invertebrates, and suggest that
novel findings in invertebrate model organisms will have a significant impact on the
understanding of vertebrate BBB functions. In this vein, important roles in coordinating
localized and systemic signaling to dictate organism development and growth are
beginning to show how the BBB can govern whole animal physiologies. This includes novel
functions of BBB gap junctions in orchestrating synchronized neuroblast proliferation, and
of BBB secreted antagonists of insulin receptor signaling. These advancements and others
are pushing the field forward in exciting new directions. In this review, we provide a
synopsis of invertebrate BBB anatomy and physiology, with a focus on insights from the
past 5 years, and highlight important areas for future study.
Keywords: invertebrates, blood-brain barrier, chemoprotection, drug delivery, conserved physiology
INTRODUCTION
In order for the nervous system to perform efficiently in coordi-
nating sophisticated movements, behaviors and cognitive func-
tions, it requires chemical isolation from the fluctuating, and
potentially damaging, components in the blood. The blood-brain
barrier (BBB) has evolved to provide this role, becoming more
sophisticated with increasing complexity and demand of the
nervous system (Abbott, 2005). Therefore, there are alternative
cellular strategies formaking BBB structures. In insects, crustacea,
cephalopod molluscs and cartilaginous fish the BBB is formed by
glial cells, whereas in higher order vertebrates the BBB is formed
primarily by the brain vascular endothelium. The formation and
functions of the vertebrate BBB are covered extensively by var-
ious reviews (e.g., Abbott, 2005; Abbott et al., 2010; Obermeier
et al., 2013) and within this BBB series; the aim of this review is
to describe the comparative compound structure and associated
physiologies of the invertebrate BBB. In recent years, the inverte-
brate BBB field has flourished with interesting insights into the
mechanisms of BBB maintenance, as well as discovering novel
metabolic and signaling roles. In addition, both established and
emerging invertebrate models are proving useful as drug screen-
ing tools to advance therapies for neurodegenerative diseases.
These findings, and others, are providing many exciting avenues
for future BBB investigations.
Abbreviations: BBB, blood-brain barrier; SPG, subperineurial glia; PG, per-
ineurial glia; CNS, central nervous system; ABC, ATP-binding cassette; SLC, solute
carrier; GPCR, G-protein coupled receptor; ARSs, actin-rich structures; IPCs,
insulin producing cells; dILPs, Drosophila insulin-like peptides
ANATOMICAL OVERVIEW OF THE INVERTEBRATE BBB
Unlike in vertebrates, the blood (hemolymph) in insects does not
circulate in a closed capillary network; instead, the hemolymph
is freely flowing in the body cavity. As a result, protection of
the insect nervous system from the high and often fluctuating
concentrations of hemolymph potassium requires that the BBB
entirely surrounds the nervous system. Therefore, at the gross
anatomical level, the invertebrate BBB is quite different from that
of the vascular endothelium in vertebrates. However, like its verte-
brate counterpart, the invertebrate BBB is a compound structure
(Figure 1), analogous to the vertebrate neurovascular unit (Stork
et al., 2008; Mayer et al., 2009; DeSalvo et al., 2011, 2014). The
invertebrate compound BBB is primarily composed of two sur-
face glia cell types [the apical perineurial glia (PG) and the basal
subperineurial glia (SPG)], and the exterior extracellular matrix
layer known as the neural lamella (Figures 1, 2). The absence
of almost all glial cells in the Drosophila glial cells missing (gcm)
mutant renders the nervous system permeable to a broad range
of fluorescent dextran molecules ranging from 10 to 500 kDa
(Stork et al., 2008), confirming the importance of glial cells for
the invertebrate BBB.
The protective functions of the invertebrate BBB are appar-
ent from embryonic stage 17 throughout development and into
the adult stage (Bainton et al., 2005; Schwabe et al., 2005; Stork
et al., 2008; Mayer et al., 2009). The PG, however, are not thought
to contribute toward these BBB properties early in development
as PG cells do not proliferate and completely surround the CNS
until late larval stages (Stork et al., 2008). The roles of the BBB
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during early development are therefore attributed to the SPG,
which entirely encapsulate the embryonic nervous system and
maintain a tight barrier throughout development and into the
adult stage (Stork et al., 2008). In order to maintain this tight
diffusion barrier, the SPG cells do not proliferate as the ner-
vous system grows; instead the SPG increase in size and become
polyploid (Unhavaithaya and Orr-Weaver, 2012). The polyploid
FIGURE 1 | Diagrammatical representation of the vertebrate and
invertebrate blood-brain barrier (BBB). The vertebrate BBB is primarily
formed by the vascular endothelial cells (VE) that form the capillaries in the
brain; however, the surrounding pericytes within the basement membrane
(BM), and the end feet of the astrocyte glia also contribute to vertebrate BBB
functions. These cellular and non-cellular layers form a compound barrier
structure known as the neurovascular unit (NVU). The invertebrate BBB is also
a compound structure, consisting of the subperineurial glia (SPG), the
perineurial glia (PG), and also a basement membrane known as the neural
lamella (NL). Both the vertebrate and invertebrate barriers express
tight/septate junction and adherens junction proteins, as well as various
xenobiotic ATP-binding Cassette (ABC) and Solute Carrier (SLC) transporters
required to maintain central nervous system (CNS) homeostasis.
nature of the SPG is essential to maintain the integrity of the
septate junctions that are present between the SPG cells, as the
nervous system grows. Inhibition of polyploidy in the SPG causes
the septate junctions to rupture and diffusion barrier integrity
to be lost (Unhavaithaya and Orr-Weaver, 2012). The formation
of the invertebrate BBB has been covered extensively elsewhere
(Stork et al., 2008; Edwards and Meinertzhagen, 2010; DeSalvo
et al., 2011).
The majority of research on the invertebrate BBB has focused
on the main BBB layer, the SPG. However, recent investigations
have started to uncover additional roles for cellular and non-
cellular layers external to the SPG cells. When the septate junction
protein Neurexin IV was mutated in Drosophila, the brain pen-
etration of 500 kDa dextran was delayed compared to in the
glial cells missing mutant, which lacks almost all glial cells (Stork
et al., 2008). This suggests that barriers other than the SPG sep-
tate junctions are present that can reduce the brain access of
certain high molecular weight molecules. It is therefore possi-
ble that the PG and neural lamella layers act as non-specific,
large molecular-weight filters. Moreover, DeSalvo et al. (2011,
2014) and Meyer et al. (2014) have recently suggested that the
PG may have signaling and metabolic roles in BBB function,
and in maintaining the neural lamella. Collagen IV, which forms
a major part of the neural lamella, is secreted by hemocytes
in the embryo and the fat body during post-embryonic devel-
opment (Mirre et al., 1988; Pastor-Pareja and Xu, 2011); but
Meyer et al. (2014) showed that, in addition to the fat body,
the Drosophila BBB can also contribute to the integrity of the
neural lamella. Mutations that affect the deposition of Collagen
IV into the neural lamella, result in deformation of the central
nervous system (CNS) and deficits in nervous system function
(Olofsson and Page, 2005; Meyer et al., 2014). Knocking out
matrix metalloproteinases specifically in the SPG or PG cells
resulted in larval lethality or an extended ventral nerve cord
phenotype, respectively (Meyer et al., 2014). This suggests that
FIGURE 2 | The cellular and non-cellular layers of the Drosophila
compound BBB. Confocal micrographs of cross sections of the adult
Drosophila optic lobe showing the localization of the neural lamella (green,
left and right panels), the perineurial glia (PG) layer (red, left panels) and
the subperineurial glia (SPG) layer (red, right panels). The left panels show
the positioning of the neural lamella (identified by the Collagen IV marker
Viking-GFP) with respect to the PG (marked by 10 kDa Texas Red Dextran
staining). The right panels show the closely apposed neural lamella
(marked by the extracellular matrix proteoglycan TROL-GFP) and SPG layer
(stained by Moody-β antibody). Scale bar, 20μm.
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the BBB glia are required to maintain the structural integrity
of the lamella, which is necessary for correct CNS shape. It
therefore appears that the glial cells of the BBB may coordinate
with the fat body to maintain and restructure the neural lamella
to respond to changing developmental and possibly metabolic
demands.
In addition to coordination between the BBB and fat body
for maintenance of BBB functions, evidence suggests that neu-
rons also have a role to play. Rbp9, which is homologous to the
RNA-binding proteins elav (invertebrates) and hu (vertebrates),
has been shown to function in maintaining BBB integrity; loss
of Rbp9 function leads to down-regulation of septate junction
proteins (primarily Neurexin IV and Coracle), and a resultant
porous BBB (Kim et al., 2010). Interestingly, Rbp9 is expressed
in neurons, but not in glia, and is therefore not expressed in
the BBB itself (Kim-Ha et al., 1999). As the Rbp9 mutants
initially form an intact BBB and only show a porous BBB
phenotype upon adult eclosion (Kim et al., 2010), it appears
that neuronal Rbp9 plays an important role in BBB mainte-
nance in invertebrates, analogous to the involvement of neu-
ronal signaling in vertebrate BBB integrity (Stewart and Wiley,
1981; Stenman et al., 2008; Daneman et al., 2009). In con-
clusion, it appears that, like the vertebrate neurovascular unit,
there is an important involvement of all layers of the inver-
tebrate compound BBB in the formation and maintenance of
the BBB.
MOLECULAR OVERVIEW OF THE INVERTEBRATE BBB
As was mentioned above, the vertebrate vascular endothelium
of the brain is specialized to provide an extremely tight barrier
to transcellular and paracellular molecular transit. This is due
to the following vascular endothelium properties: tight junction
complexes between the vascular endothelium cells; enrichment
of efflux ABC transporters, which are localized to the apical
(luminal) face of the vascular endothelium; low rates of tran-
cytosis due to reduced vesicular trafficking (Muir and Peters,
1962; Reese and Karnovsky, 1967; Brightman and Reese, 1969;
Daneman et al., 2010; for reviews see Zlokovic, 2008; Abbott
et al., 2010; Obermeier et al., 2013). Many of these molecular
properties are also shared by the invertebrate BBB. As alluded
to above, the SPG cells of the invertebrate BBB form a tight
barrier to paracellular transit due to the presence of pleated
septate junctions. These complexes are equivalent to the sep-
tate junctions that perform electrical and chemical insulation
properties at the axo-glial paranodal junctions (Bhat et al.,
2001; Bhat, 2003). SPG cells also express efflux ABC trans-
porters, in particular the ABC B1 xenobiotic efflux transporter
Mdr1/P-glycoprotein homolog (Mdr65) is both highly enriched
and shows apical localization in the SPG cells (Mayer et al.,
2009; DeSalvo et al., 2014). In addition to the chemoprotec-
tive properties, the BBB must also regulate the brain access of
endogenous molecules, such as glucose and ions. For this, the
BBB expresses various solute carrier proteins (SLCs). Recent evi-
dence from Drosophila has also suggested interesting roles for
the gap junctions that are expressed in both the vertebrate and
invertebrate BBB. These findings are discussed in more detail
below.
CHEMOPROTECTIVE ROLES OF THE INVERTEBRATE BBB
Septate junction formation and maintenance
The primary barrier of the invertebrate BBB is provided by the
septate junctions, the functional equivalent of the vertebrate tight
junctions and paranodal septate junctions. The formation and
maintenance of a tight diffusion barrier protects the invertebrate
nervous system from the high concentrations of potassium in
the hemolymph; without this barrier, the embryos are unable to
fire action potentials and cannot coordinate movements to hatch
from the embryonic cuticle. Septate junction mutations therefore
cause a porous BBB and embryonic lethality (e.g., Baumgartner
et al., 1996; Schwabe et al., 2005; Stork et al., 2008). The 5 main
components of the septate junctions are the membrane compo-
nents Neurexin IV (Caspr in vertebrates), Neuroglian (vertebrate
Neurofascin 155), ATPα and Nervana2 (Na+/K+ ATPase α and
β subunits), and the intracellular component Coracle (protein
4.1 in vertebrates); however additional proteins are also thought
to contribute toward the integrity and maintainance of the sep-
tate junctions, including Gliotactin (vertebrate Neuroligin-like),
Contactin (vertebrate Contactin), Discs large (Dlg; vertebrate
PSD-95-like), Fasciclin III, Moody, Sinuous, and Megatrachea
(the latter 2 are vertebrate claudin-like proteins) (Fehon et al.,
1994; Auld et al., 1995; Baumgartner et al., 1996; Behr et al., 2003;
Genova and Fehon, 2003; Paul et al., 2003; Schulte et al., 2003;
Faivre-Sarrailh et al., 2004; Bainton et al., 2005; Schwabe et al.,
2005; Stork et al., 2008; Oshima and Fehon, 2011). The septate
junction proteins interact with each other to form stable septae
contacts between SPG cells that surround the CNS (Figure 3).
Disruption of any septate junction component leads to a porous
BBB phenotype, suggesting that they function interdependently
to maintain BBB function. To further address the relationship
between septate junction components, Oshima and Fehon (2011)
investigated the dynamics of septate junction-associated proteins.
Using fluorescence recovery after photobleaching (FRAP), they
elegantly showed that the 5 main septate junction components
form a very stable core unit, whereas other septate junction-
associated proteins (e.g., Dlg) are more mobile. In addition, they
discovered that mutating different septate junction-associated
proteins had different mechanisms for causing a defective BBB.
Loss of some septate junction-associated proteins (e.g., Dlg)
caused delayed formation of the stable septate junction core;
however, the dynamics of this stable core, once formed, was not
affected by Dlg mutation. Furthermore, the loss of Gliotactin or
endocytic proteins, such as clathrin heavy chain or theDrosophila
dynamin homolog shibire, led to a mislocalisation of the core sep-
tate junction proteins, but had no effect on septate junction core
formation (Oshima and Fehon, 2011).
Interestingly, a particular splice form of Neurexin IV (contain-
ing exon 3) was shown to be the septate junction-forming version
of Neurexin IV and has been shown to be preferentially expressed
in glia over neurons (Rodrigues et al., 2012). The mechanism of
cell-specific splicing has recently been elucidated in Drosophila
using elegantly designed genetic reagents that revealed the tran-
script pattern of the Neurexin IV isoform(s) present in neurons
vs. glia (Rodrigues et al., 2012). The authors found that the cell-
specific splicing of Neurexin IV involves the RNA-binding protein
HOW (Held out wings). HOW is not expressed in neurons, but
www.frontiersin.org December 2014 | Volume 8 | Article 414 | 3
Hindle and Bainton Barrier mechanisms in the Drosophila blood-brain barrier
FIGURE 3 | Septate junction formation and maintenance in the
invertebrate BBB. Components of the core septate junction (green) and the
associated proteins that maintain BBB integrity (black) were identified from
loss of function mutants that led to a porous BBB phenotype. Discs large
(Dlg) mutants showed delayed assembly of the core septate junction
components, whereas mutants of Gliotactin, and the endocytic proteins
Clathrin-heavy chain (Chc) and Shibire, showed a mislocalization of the
septate junction core. The Moody GPCR signaling pathway (Moody, Gαo /Gα i ,
loco) was shown to genetically interact with actin and non-muscle myosin
components [actin-rich structures (ARS), Zipper, Spaghetti squash (Sqh)] to
maintain septate junction integrity. Kinesin heavy chain (Khc) may regulate
septate junction integrity by transporting Neurexin IV as a cargo protein. Loss
of septate junction integrity by disrupting the function of wunen, the lipid
phosphate phosphatase, suggests a role for bioactive lipids in paracellular
barrier function. NL, neural lamella; PG, perineurial glia; SPG, subperineurial
glia; CNS, central nervous system; kune (kune-kune).
ectopic neuronal expression of the constitutively nuclear form of
HOW leads to a shift in Neurexin IV isoform expression to that
of a glial pattern, leading to larval lethality. This showed that the
expression and nuclear localization of HOW in glia predisposes
glia to expression of the Neurexin IV (exon 3) form, promot-
ing the formation of septate junctions. Rodrigues et al. (2012)
showed the additional involvement of the kinase Cdk12 and the
splicesomal component Prp40 in HOW function.
Recently, another claudin-like protein (Kune-kune) and a
leukocyte antigen 6 family protein (Coiled) were identified in
screens for disrupted BBB integrity (Nelson et al., 2010; Hijazi
et al., 2011; Syed et al., 2011). The protein Kune-kune colocal-
izes with the septate junction component Coracle. Its localization
is dependent on the presence of various septate junction compo-
nents (e.g., Coracle, ATPα, Sinuous andMegatrachea) and, recip-
rocally, septate junction component localization is dependent on
the presence of Kune-kune (Nelson et al., 2010). The authors
discovered that Kune-kune regulates both septate junction local-
ization and levels, whereas the other claudin-like proteins Sinuous
and Megatrachea regulate septate junction component levels and
localization, respectively. Analysis of septate junction levels and
localization in single, double and triple mutants of these three
claudin-like proteins showed that Kune-kune seems to have a
more important role in coordinating septate junction compo-
nents than Sinuous and Megatrachea (Nelson et al., 2010). The
Ly6 family protein Coiled is required for septate junction forma-
tion in the embryo; Coiledmutations cause disrupted localization
of septate junction proteins, including Neurexin IV, Coracle and
Discs large, therefore abrogating BBB integrity (Hijazi et al., 2011;
Syed et al., 2011).
The G protein-coupled receptors (GPCRs) encoded by the
moody gene (Moody-α and Moody-β) are required to regulate
BBB permeability (Bainton et al., 2005; Schwabe et al., 2005).
In addition, the trimeric G proteins Gαi and Gαo, and the reg-
ulator of G protein signaling (RGS) loco are thought to signal
in the same Moody pathway to regulate septate junction forma-
tion and maintenance (Schwabe et al., 2005). Mutations in any of
these four components leads to a porous BBB and locomotor dys-
function; however, themoody null has a weaker BBB permeability
to 10 kDa dextran compared to the Gαi, Gαo, and loco mutants,
suggesting that these latter components of the GPCR signaling
pathway may have additional upstream or downstream signal-
ing partners involved in septate junction integrity. Interestingly,
because loco is a negative regulator of GPCR signaling, this means
that both loss and gain of GPCR signaling disrupts BBB integrity.
This suggests that discreet, and localized control over this sig-
naling pathway is required for correct septate junction formation
and maintenance. That being said, the effect on septate junction
integrity appears to be a secondary effect of disrupted GPCR sig-
naling on the actin cytoskeleton and cell size/shape, which leads
to reduced undulations of the SPG cells and a shortening of the
septate junction length (Schwabe et al., 2005). As the length of
the septate junction dictates the tightness of the BBB, this creates
a more permeable septate junction barrier in moody mutants.
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Additional evidence that BBB integrity requires the
coordination of Moody signaling and actin dynamics was
recently provided by Hatan et al. (2011). They discovered that
highly dynamic actin-rich structures (ARSs) are localized in close
proximity to, but not overlapping with, the septate junctions; the
ARSs colocalized with the fusion proteins Neuroglian-GFP and
Scribble-GFP, but not with Neurexin-IV. The regulation of ARS
morphology and size was shown to require Moody signaling and
also activation of non-muscle myosin components Zipper and
Spaghetti squash, which are thought to be downstream of Moody
signaling (Hatan et al., 2011). Disruption of ARSs by knocking
down the actin nucleation components Arp2 and Arp3 led to
dissociation of ARSs and Neuroglian, discontinuous Neuroglian
labeling at the septate junction, and breakdown of BBB integrity.
These findings suggest an interesting possibility that ARSs
act as dynamic docking sites for septate junction components
to allow their rapid incorporation into the septate junctions
during development to maintain a tight BBB as the brain grows
(Figure 3). Although the ARSs were only detectable during
development, and not during adult stages (Hatan et al., 2011),
it would be interesting to determine whether similar structures
have a transitory role in the adult, perhaps during circumstances
of BBB challenge (chemical, physical or pathological).
Another regulator of BBB integrity, the Kinesin heavy chain,
was recently identified from a 5000 candidate-gene screen for
locomotion defects (Schmidt et al., 2012). Kinesin heavy chain
is classically known for its role in axonal transport. However,
Schmidt et al. (2012) discovered an important role within SPG
cells. Knocking down Kinesin heavy chain specifically in SPG cells
led to disrupted axonal excitability resulting in spasticity in adult
flies. They found that one of the cargoes of a Kinesin heavy
chain-dependent Rab protein is Neurexin-IV, suggesting that
Kinesin heavy chain may contribute toward the control of neu-
ronal excitability by regulating Neurexin-IV incorporation into
the septate junctions of the SPG cells. The vertebrate homologs of
Drosophila Kinesin heavy chain are members of the KIF5 fam-
ily. Both KIF5A and KIF5C are mainly expressed in neurons,
but KIF5B shows some expression in glia (Kanai et al., 2000);
however, no specific roles have been found for KIF5B in glia.
Interestingly, the kinesin KIF13B has been shown to transport
Discs large 1 (Dlg1) to sites of membrane remodeling during
myelin formation in the Schwann glial cells that insulate the
peripheral nervous system (Bolis et al., 2009). Therefore, homolo-
gous roles may exist for Kinesin heavy chain proteins in regulating
tight junction integrity in the vertebrate BBB.
Wunen is a lipid phosphate phosphatase (LPP), an integral
membrane enzyme that, in vertebrates, is required in the reg-
ulation of bioactive lipids (e.g., sphingosine-1-phosphate). In
Drosophila, Wunen is known for its role in germ cell survival and
migration (Zhang et al., 1997; Starz-Gaiano et al., 2001); however,
it has recently been shown to also localize to septate junctions and
to function in septate junction maintenance both in trachea and
the BBB (Ile et al., 2012; Figure 3). Wunen mutant nerve cords
show increased permeability to 10 kDa dextran, comparable to
that of a Neurexin-IV mutant (Ile et al., 2012). A role for bioac-
tive lipids in the maintenance of BBB integrity has previously
been show in mammalian brain microvascular endothelial cells
grown in culture (Lee et al., 2006). Treatment with sphingosine-
1-phosphate caused relocalization of tight junction/cell-cell con-
tact proteins (including ZO-1 and claudin-5) and increased the
trans-epithelial electrical resistance. Also, an in vivo role for the
mammalian LPP3 in the formation of vascular endothelial cell
interactions was shown during development (Escalante-Alcalde
et al., 2003). This shows that the role for bioactive lipids in
BBB formation and maintenance is evolutionarily conserved, and
supports the notion that the invertebrate septate junctions are
functionally andmechanistically equivalent to the vertebrate tight
junctions.
Xenobiotic efflux transporters
In the vertebrate vascular endothelium, the tight junctions pro-
vide chemoprotection to the brain by preventing the entry of
molecules via the paracellular route. However, another mecha-
nism is required to prevent transcellular access to the brain. This
is provided by the xenobiotic efflux transporters (Figure 4). These
transporters belong to the ATP-binding cassette (ABC) B, C, and
G classes, and are localized to the apical membrane of the vas-
cular endothelium. The xenobiotic efflux transporters are well-
characterized for their role in removing lipophilic xenobiotics
from the plasma membrane (Leslie et al., 2005), preventing access
into the brain. Hence, these transporters are a major hindrance
to the successful delivery of therapeutics into the brain (Abbott
and Romero, 1996; Abbott, 2013). The main xenobiotic efflux
transporters at the BBB are P-glycoprotein (P-gp/ABCB1/Mdr1)
and Breast Cancer Resistance Protein (BCRP/ABCG2). In inverte-
brates a transcellular transport-barrier has been identified in the
SPG cells, which is provided by the homolog of P-glycoprotein
(Mdr65; Mayer et al., 2009). Drosophila Mdr65 shares 42%
sequence identity with P-glycoprotein. In the Drosophila brain,
Mdr65 expression is restricted to the SPG layer of the BBB and,
like P-glycoprotein, localizes to the apical membrane. Mayer et al.
(2009) identified Mdr65 in a screen for increased BBB perme-
ability to the P-glycoprotein substrate Rhodamine B. Mdr65 is
also required at the BBB to protect the brain from various P-
glycoprotein xenobiotic substrates, and sensitivity of the Mdr65
mutants to these xenobiotics can be rescued by expression of
human P-glycoprotein specifically in the SPG cells, confirming
that Mdr65 provides an evolutionarily conserved chemoprotec-
tive transport barrier at the invertebrate BBB. Interestingly, recent
work in the migratory locust (Locusta migratoria) and the desert
locust (Schistocerca gregaria) has shown that P-glycoprotein-like
xenobiotic transporters also provide a transcellular barrier in
the locust brain (Nielsen et al., 2011; Andersson et al., 2013).
These findings advance the possibilities of using insect models to
study the roles of xenobiotic efflux transporters at the BBB (see
below).
In addition to Mdr65, other potential homologs of mam-
malian chemoprotective ABC transporters are expressed at
the invertebrate BBB (DeSalvo et al., 2014). These candidates
were identified based on their expression or enrichment in
the adult Drosophila BBB; these include putative homologs
for ABCC-/MRP-1, 4, 5 and 6 (CG5789, SUR, CG11897, and
MRP) and ABCG2/BCRP (W, CG31689 and CG3164). Currently,
there are no published reports showing whether these gene
www.frontiersin.org December 2014 | Volume 8 | Article 414 | 5
Hindle and Bainton Barrier mechanisms in the Drosophila blood-brain barrier
FIGURE 4 | Chemoprotective and endogenous molecule transporters of
the invertebrate BBB. The transcellular chemoprotective barrier is primarily
provided by the ATP-binding Cassette (ABC) transporters. These xenobiotic
efflux transporters are localized to the apical surface of the subperineurial glia
(SPG) and remove lipophilic molecules from the SPG membrane, preventing
access to the brain. Members of the Solute Carrier (SLC) class of
transporters also have some chemoprotective roles, but are mainly known as
transporters of endogenous molecules. The SLCs control the entry of
hydrophilic/charged molecules (e.g., glucose, amino acids and ions) into the
brain, to support optimal brain function. SLCs are present both on the apical
and basal surfaces of the SPG cells. Some SLC members, e.g., Oatp58Dc,
are also expressed in the perineurial glia (PG). Red and white hexagons
represent xenobiotics and endogenous molecules, respectively. NL, neural
lamella; CNS, central nervous system.
products can perform chemoprotective functions at the inverte-
brate BBB.
The vertebrate organic anion transporters (Oats and Oatps)
are primarily known for their roles in controlling the brain
access of endogenous anions (Kusuhara and Sugiyama, 2005);
however, they also have chemoprotective functions (Anderson
and Thwaites, 2010). Potential homologs of vertebrate Oats and
Oatps are also expressed at theDrosophila BBB (CG6126,CG3168,
CG6231, ORCT2, CG4630, ORCT, Oatp58Dc, and Oatp74D;
DeSalvo et al., 2014), providing candidates for determining
whether Oat/Oatps can also contribute toward chemoprotection
of the brain in invertebrates. The Drosophila genome encodes
eight Oatp transporters, two of which have enriched transcript
number in the Drosophila brain (Oatp58Dc and Oatp74D; http://
flyatlas.org/). Seabrooke and O’Donnell (2013) have recently
shown that Oatp58Dc is expressed in the PG, SPG and post-
mitotic neurons, and is required specifically in PG cells for
maintaining chemical protection of the brain from fluorescein.
In the absence of Oatp58Dc, levels of hemolymph-injected fluo-
rescein are higher in the brains of Oatp58Dc Drosophila brains.
This shows that, at least for Oatp58Dc, invertebrate organic
anion transporters can also provide chemoprotective functions to
the BBB.
ENDOGENOUS MOLECULE REGULATION
Transcellular access to the brain is not only controlled by ATP-
dependent xenobiotic efflux transporters; secondary/facilitated
transporters and channel proteins are also expressed at the BBB in
both vertebrates and invertebrates (Figure 4). The largest group
of the facilitated transporters is the solute carrier (SLC) trans-
porters. In vertebrates, the SLCs are grouped into 48 classes
(SLC 1–48) based on sequence identity (Hediger et al., 2004).
It was recently documented that Drosophila glia express SLCs
from eight of these vertebrate SLC classes (SLC1, SLC5, SLC6,
SLC7, SLC24, and SLC29), but it was not determined whether
these SLCs were expressed or enriched in the BBB (Featherstone,
2011). Microarray analysis of the adult Drosophila BBB glia has
recently identified which of these SLCs are expressed or enriched
at the BBB, and also identified additional BBB SLC class candi-
dates (DeSalvo et al., 2014). Of note, there are 18 SLC homologs
that are both highly expressed and enriched at theDrosophila BBB
(members from the SLCO, 2, 7, 16, 19, 22, and 39 classes) and
would therefore be good candidates for further study.
A role for the SLC12 transporter Ncc69 (a cation chloride
cotransporter) and its serine/threonine kinase regulator Fray has
been shown in controlling extracellular volume in peripheral
nerves (Leiserson et al., 2011). Mutants in either Ncc69 or Fray
lead to the accumulation of fluid between axons and glia, resulting
in peripheral neuropathy. Both Ncc69 and Fray were also shown
to function in the SPG cells of the blood-nerve barrier.
Eight potential SLC21 (Oatp) transporters have been identified
in Drosophila (Seabrooke and O’Donnell, 2013). Of these eight,
four are expressed in the Drosophila head or brain (Oatp30B,
Oatp33Ea, Oatp58Dc, and Oatp74D; http://flyatlas.org/; Torrie
et al., 2004; Seabrooke and O’Donnell, 2013). According to the
data in DeSalvo et al. (2014), Oatp30B is primarily expressed in
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neurons, however, Meyer et al. (2014) suggested a glial role for
Oatp30B in neural lamella integrity and CNS shape. Oatp33Ea
shows very low expression in all cell types of the adult brain; as
its expression was previously shown in the fly head, Oatp33Ea
may therefore localize to the fat bodies of the head rather than
the brain. As mentioned above, the organic anion transporter
Oatp58Dc is expressed in the PG, SPG and post-mitotic neu-
rons of the Drosophila CNS; however, its function was shown to
be specifically required in the PG layer of the BBB (Seabrooke
and O’Donnell, 2013). This suggests a novel role for the PG in
regulating organic anion access to the brain. Oatp74D was also
shown by DeSalvo et al. (2014) to be highly enriched in the BBB
(21-fold and 64-fold enrichment compared to whole brain and
neuron levels, respectively). It would be interesting to determine
the function of this transporter, whether it is required in the SPG
or PG, and whether there is any overlap or coordination in the
BBB functions of Oatp58Dc and Oatp74D.
Although the BBB provides a paracellular barrier to the move-
ment of inorganic ions between the hemolymph and the brain,
transcellular transit does occur (Treherne, 1966). This involves
both energy-dependent mechanisms (Na+/K+ ATPases) and also
diffusion down the electrochemical gradient, which may be par-
tially set up by V-type H+-ATPases (Kocmarek and O’Donnell,
2011).
Another mode of transit across the BBB is provided by
receptor-mediated transcytosis. In general, vesicular transcyto-
sis is reduced in the vascular endothelial cells of the verte-
brate BBB; however, small and large molecular weight molecules
can transit the BBB by a specific, receptor-mediated route (see
Xiao and Gan, 2013 for review). In Drosophila, the mecha-
nism of receptor-mediated transcytosis of lipoprotein via the
low-density lipoprotein receptor (LRP) has recently been inves-
tigated (Brankatschk and Eaton, 2010; Brankatschk et al., 2014).
Lipophorin is the main lipoprotein present in Drosophila. The
protein component of lipophorin (apolipophorin) can be cleaved
into ApoLI and ApoLII, and this cleavage was shown to affect
the localization of the lipoprotein once it had transited across
the BBB. The full length ApoL localized to neurons, whereas
ApoLII was found in the optic anlage. The authors further inves-
tigated the function of lipophorin in the brain and found that
knocking down the production of lipophorin in its synthesis
organ (the fat body) blocked neuroblast proliferation in the
first/second instar larvae. They suggest that this may be due
to the reduced BBB transit of GPI-linked proteins, which they
show requires the presence of lipophorin. Brankatschk and Eaton
(2010) also showed that lipophorin-associated, sterol-linked flu-
orescent proteins only have limited access to the brain and pri-
marily accumulate at the BBB. From this, one might conclude
that sterol-linked proteins don’t play a role in neuroblast prolif-
eration as they scarcely enter the brain; however, recent work in
the Brand lab discovered a role for synchronized BBB calcium
signaling in coordinated neuroblast proliferation (Speder and
Brand, 2014; see below). Therefore, sterol-linked proteins may
not need to enter the brain to induce neuroblast proliferation.
Instead their accumulation in the BBB may trigger a signaling
cascade that induces the underlying neuroblasts to proliferate.
Brankatschk et al. (2014) have also shown that BBB calcium
release is required for the BBB transit and normal brain localiza-
tion of Lipid Transfer Particle. This was shown to be important
for the insulin-dependent regulation of systemic growth (see
below).
METABOLIC AND SIGNALING ROLES OF THE INVERTEBRATE BBB
The previous sections have primarily dealt with the anatomy and
function of the invertebrate BBB in chemoprotection of the brain,
regulation of endogenous molecule access to the brain, and the
maintenance of these functions. However, the BBB acts as more
than just a selective filter. Exciting new findings have revealed
that the Drosophila BBB can also sense and respond to systemic
metabolic signals (Chell and Brand, 2010; Speder and Brand,
2014). Thus, the BBB appears to be a dynamic and communica-
tive layer between the brain and the body (Figure 5). The insulin
signaling pathway has long been known to sense nutritional status
and dictate organism growth, reproductive output and lifespan,
and this is evolutionarily conserved (Partridge et al., 2011; Wigby
et al., 2011; Mirth and Shingleton, 2012). This systemic signaling
is coordinated by the secretion of Drosophila insulin-like peptides
(dILPs), which are secreted by insulin producing cells (IPCs) in
the brain. The secretion of dILPs is triggered by a factor produced
by the fat body (the Drosophila liver and adipose tissue equiva-
lent) in response to dietary amino acids [through the Slimfast
and target of rapamycin (TOR) signaling pathways; Geminard
et al., 2009], and fat and sugar (through the Drosophila cytokine
Unpaired2; Rajan and Perrimon, 2012; reviewed in Nassel et al.,
2013). In addition to the IPCs, the BBB glia have recently been
shown to be a source of dILPs required for the reactivation of
proliferation in the underlying neuroblasts (Chell and Brand,
2010; Speder and Brand, 2014; Figure 5). The BBB glia expres-
sion of dILP2 and dILP6 is nutrient-dependent, suggesting that
a humoral signal from the fat body (possibly Unpaired2; Rajan
and Perrimon, 2012) is sensed by the surface glia leading to
dILP production and secretion to reactivate neuroblast prolif-
eration in the larval brain (Chell and Brand, 2010). It would
be interesting to determine whether this humoral signal is the
same signal that depends upon lipophorin particles to induce
neuroblast proliferation, as shown by Brankatschk and Eaton
(2010).
Additional evidence for the role of BBB glia in coordinat-
ing neuroblast proliferation was provided by Speder and Brand
(2014) who discovered that gap junctional proteins expressed
in the SPG cells were required for synchronized calcium oscil-
lations within the SPG, and for neuroblast proliferation. The
synchronized calcium oscillations were nutrient-dependent, and
were therefore suggested to be a bridge in the gap between
the nutrition-dependent fat body-derived signal and the syn-
chronous nutrient-dependent exit of neuroblasts from quies-
cence. Although this work suggests a direct role for the BBB glia
in neuroblast proliferation, Sousa-Nunes et al. (2011) suggest that
neuroblast proliferation requires dILP6 expression by the under-
lying cortex glia rather than the SPG cells. Therefore, the role
of the BBB may be to coordinate a complex signaling network,
bringing together systemic nutritional signals and relaying this
information to the underlying cortex glia to regulate neuroblast
proliferation (Figure 5).
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FIGURE 5 | Metabolic and signaling roles of the invertebrate BBB. The
Drosophila BBB can sense and respond to various systemic signaling inputs.
This includes the lipoprotein-like receptor (LRP) ligand lipophorin (LPP), the
cytokine-like molecule Unpaired-2 (Upd2) and other unidentified signaling
molecules (??) that are released in response to metabolic/nutritional triggers.
This leads to localized secretion of Drosophila insulin-like peptide (dILP) by
the subperineurial glia (SPG) and/or cortex glia (CG) to coordinate neuroblast
(NB) proliferation. The coordinated response of the SPG is thought to occur
through synchronous calcium (Ca2+) oscillations via gap junction proteins. In
addition to localized growth regulation, the Drosophila BBB can also regulate
systemic growth (whole organism growth). The SPG cells both express and
constitutively secrete a negative regulator of insulin signaling: the secreted
decoy of insulin receptor (SDR); SDR mutants lead to excessive growth of
the whole animal.
In extension of this work, Brankatschk et al. (2014) have shown
that the BBB can also regulate growth systemically (whole organ-
ism growth) in addition to localized growth control (neuroblast
proliferation). They found that the BBB controls Lipid Transfer
Particle brain access and localization to Dilp2-recruiting neurons
in the brain; this resulted in systemic secretion of Dilp2 from
insulin producing cells in the brain, impacting onwhole organism
growth. This BBB function is nutrition-dependent and requires
calcium signaling in the BBB. In fact, genetic manipulations that
forced an increase in BBB calcium release resulted in normal sys-
temic insulin signaling despite an inappropriate nutritional state.
Together, these fascinating findings show that the BBB can have a
master role in linking nutritional input to both local and systemic
growth outputs.
A further role for the Drosophila BBB in growth control was
shown by Okamoto et al. (2013). The authors discovered a nega-
tive regulator of insulin signaling, the secreted decoy of insulin
receptor (SDR), in an RNAi screen for secreted regulators of
body growth; SDR mutants had a larger body weight. SDR is
expressed in the BBB glia of the CNS, the midgut muscles and
imaginal discs of the larva; however, its function in body growth
was shown to be dependent on its BBB glia expression (Okamoto
et al., 2013). Although SDR expression and secretion was shown
to be constitutive, and not dependent on nutritional status, it
proved to be crucial for controlling body weight during adverse
nutritional conditions; SDR mutants were lethal when grown in
adverse nutritional conditions whereas wild type larvae survived.
These results suggest a further role for the BBB in controlling
body growth during development. The body size of the adult fly
is predetermined during the larval and pupal stages (Mirth and
Shingleton, 2012); however, DeSalvo et al. (2014) showed that
SDR is highly expressed and enriched in the BBB glia of the adult
brain. Therefore, this begs a number of questions.What is the role
of SDR in the adult? Is its secretion regulated or constitutive in the
adult? Does its expression level change with age? Does SDR have
a role in regulating aging? These are exciting questions that can
easily be addressed in the Drosophila model organism.
This additional role of the BBB in coordinating both localized
and systemic insulin signaling to regulate localized and organism-
wide growth is likely to be one in a number of ways that the BBB
can communicate with various organs of the body.
THE INVERTEBRATE BBB AS A TOOL FOR ADVANCING
THERAPEUTIC INTERVENTIONS
One of the major hindrances in neuropharmacology is the resis-
tance of the BBB for drug delivery to the brain. This is primarily
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due to the efficient functioning of P-glycoprotein. Furthermore,
the pre-clinical to clinical translation of CNS drug penetration
following the use of P-glycoprotein inhibitors has proved unsuc-
cessful due to incomplete P-glycoprotein inhibition (see Kalvass
et al., 2013 for a detailed review). Therefore, being able to develop
drugs that are not P-glycoprotein substrates would be a benefi-
cial strategy. Drug screening largely depends upon in vitro tests
using brain microvascular endothelial cell monolayers. However,
studies have shown that brain microvascular endothelial cells
grown in culture do not maintain their full BBB properties; of
particular note, they show a down regulation of P-glycoprotein
(Calabria and Shusta, 2008), suggesting that this methodology
is not ideal. Early phase drug screening using rodents would be
too costly; therefore, there is a need for a cost-effective in vivo
approach to further the development of CNS drugs. With this in
mind, DeSalvo et al. (2011) developed an approach to perform
live screening of chemical fluor penetration into the Drosophila
brain. This approach involved visualizing a change in the fluores-
cence intensity in the fly eye, due to a change in permeability of
the blood-eye barrier. DeSalvo et al. (2011) showed this approach
could be used to screen for genetic modifiers of BBB integrity and
identified various interesting candidate genes that were expressed
in different layers of the compound BBB, supporting the notion
that all layers of the compound barrier are important for full
BBB integrity. In addition to genetic modifiers, this live imaging
approach can be used for large-scale drug screening to identify
drugs that will penetrate the BBB and are therefore not likely
P-glycoprotein (Mdr65) substrates.
Interestingly, other invertebrate BBB models have been devel-
oped to allow in vivo drug screening. Using the grasshopper
system, Nielsen et al. (2011) showed that co-administration of
a P-glycoprotein inhibitor with a test P-glycoprotein substrate
rendered the BBB more permeable to the P-glycoprotein sub-
strate. Furthermore, Andersson et al. (2013) were able to use
this methodology to distinguish P-glycoprotein substrates from
non-substrates using liquid chromatography-mass spectrome-
try to measure the drug content in the brain, either in the
absence or presence of a P-glycoprotein inhibitor. This con-
firmed that P-glycoprotein substrates could be identified using
this model system. These invertebrate BBBmodels provide a valu-
able bridge between endothelial cell culturemodels and vertebrate
P-glycoprotein knock-out models for drug screening.
In addition to using invertebrate BBB models to assess BBB
permeability of test drugs, these model systems can also be used
to test new technologies for increasing drug delivery to the brain.
The cost of performing these trials in invertebrates would be com-
paratively small and would therefore allow for a much broader
scaled testing strategy than can be applied to vertebrate sys-
tems. The use of Drosophila to address the problem of brain
drug delivery was shown by Sarantseva et al. (2011), where they
tested the ability of dendrimers to cross the BBB. Dendrimers
are nanopolymers that can encapsulate various cargo and there-
fore have been utilized in many biological (and non-biological)
fields (see Kesharwani et al., 2014 for a review). The advantage of
using these nanopolymers as a CNS drug delivery strategy is the
ability to customize the dendrimer to very specific requirements.
For example, the functional group on the polymer surface can be
modified to allow tissue-specific targeting, and they are also able
to “carry” various types of cargo, including nucleic acids, pro-
teins and drugs across cell membranes (Kesharwani et al., 2014).
The use of these biological vectors in drug delivery have been
shown for epithelial barriers, such as the skin and intestine (e.g.,
Kaminskas et al., 2012). Moreover, the ability of the lysine-based
dendrimer D5 to carry peptides across the Drosophila BBB has
been shown (Sarantseva et al., 2011), suggesting that this nan-
otechnology could be a useful strategy for improving CNS drug
delivery in vertebrates.
FUTURE QUESTIONS AND EMERGING AREAS OF BBB
RESEARCH
We have highlighted that the invertebrate BBB is a compound
structure, like the vertebrate neurovascular unit, and each of its
cellular and non-cellular layers appears to have a coordinated
role in maintaining BBB integrity and for signaling purposes.
However, there is still much to learn about the nature of the com-
munication between these layers, how this is regulated, and how
the individual layers respond to physical, chemical or pathological
perturbations. In particular, understanding the compensations
that occur within these BBB layers during a disease state will likely
be required to advance therapeutic design to combat these disor-
ders. Expression changes of chemoprotective transporters, such as
P-glycoprotein and Breast Cancer Resistance Protein, have already
been shown to occur in disease states including Alzheimer’s dis-
ease and epilepsy (Vogelgesang et al., 2002; Loscher and Potschka,
2005; Miller, 2010). These expression changes are thought to
explain the multidrug resistance phenotypes seen in some neu-
rological disorders. Therefore, investigations that show ways to
counter these compensations would be valuable for treating these
diseases. Furthermore, being able to parse the contribution of
the PG and SPG toward CNS protection would be a valuable
endeavor. This could involve a genetic approach, like used by
DeSalvo et al. (2014), to produce separate PG and SPG transcrip-
tomes in both the wild type and diseased states.
In addition to parsing the contributions of the SPG and PG
toward BBB function, an important future question for the field
is to determine whether there are regional specializations across
the invertebrate compound BBB. We have seen evidence of coor-
dinated BBB functions via gap junction signaling within the SPG
cells, which impacted upon the synchrony of neuroblast prolifer-
ation (Speder and Brand, 2014); equally possible is the presence
of regional BBB responses to localized signals, in terms of devel-
opmental and pathological signals, as well as localized immune
cell transmigration. In extension of this, it is important to under-
stand how the different layers of the compound BBB network
can respond to localized signals and perturbations. For example,
it would be interesting to determine whether there are different
subsets of underlying cortex glia that can sense and respond to
chemical perturbations of the BBB and other subsets that can
respond to the metabolic status of the CNS, to provide both
broad and localized “feedback circuitry” to relay information
about CNS homeostasis to the BBB. Due to the powerful genetic
strengths of the Drosophila system and the accessible architecture
of the invertebrate BBB, this is an area where invertebrate model
organisms can help to pave the way forward.
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An exciting, emerging area of BBB research that deserves fur-
ther attention is whether there are sex-specific traits of the BBB. It
is already known that there are sex-specific differences in the CNS,
a concept that is evolutionarily conserved (Cachero et al., 2010).
However, very little is known about sex-specific components of
the BBB and its impact on physiology. This is another research
area where Drosophila can advance the field, as it is possible to
specifically change the sex of the BBB using targeted genetics. This
allows the separation of sex-specific BBB effects from sex-specific
effects of the whole organism. This approach is possible because
sex determination is cell autonomous in flies; therefore, one can
express a master regulator of sex determination (e.g., TraF) in
a specific cell type and alter the sex identity of that cell type.
This has been shown for the Drosophila liver and adipose tissue
equivalent (the fat body), showing that male courtship behav-
ior can be altered by changing the sex identity of the fat body
cells (Lazareva et al., 2007). This technique was recently applied
to the BBB, showing a behavioral impact of sex-specificity in the
BBB (Hoxha et al., 2013). BBB-specific, ectopic expression of a
gene that feminizes cells (TraF) led to reduced courtship behav-
ior in males. Hoxha et al. (2013) showed that this was not solely
a developmental effect, as BBB-specific expression of TraF only
during the adult stages of the fly still reduced courtship in males.
The authors also showed that this reduction in courtship behavior
required the GPCR Moody, which Bainton et al. (2005) previ-
ously showed to have separable roles inmaintaining BBB integrity
(a structural role) and behavioral drug responses (a signaling
role). Interestingly, there are sex-specific enrichments of Moody
isoforms in the BBB (Hoxha et al., 2013). Of the four Moody iso-
forms, there is an enrichment of one of the Moody-α isoforms
in male heads and an enrichment of both Moody-β isoforms in
female heads. Therefore, Hoxha et al. (2013) have already identi-
fied that sex-specific transcripts do exist in the BBB and that sex
identity of the BBB can impact upon behavior. It would be inter-
esting to determine whether sex-specific differences in the BBB
can also impact upon pharmacokinetics, as this could have major
implications for treatments of CNS disorders.
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